サイエンス
00
Technology for the heart
About a decade ago, the cardiovascular research group at Novartis began investigating a potential drug target for heart failure. But while none of the available methods yielded useful results, a new approach for studying miniature muscles turned out to be a perfect match for what the group needed. The resulting mini-heart platform has since developed into a powerful research tool.
Text by K.E.D Coan and Jovana Rakovic, photos and videos by Bryce Vickmark and David Poller.
en
de
zh
jp
Share
en
de
zh
jp
Share
